$0.0312
-0.086-73.38%
Last update: May 30, 8:00 AM
$0.0312
-0.086-73.38%
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc.
SYRSOTCEM
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. (SYRS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.72 | $-0.77 | $-0.87 | $-1.14 |
| Actual | $-0.16 | $-0.59 | $-0.10 | $-2.18 |
| Surprise | +77.8% | +23.4% | +88.5% | -91.2% |
| Revenue | ||||
| Estimate | $450000 | $460000 | $720000 | $2.0M |
| Actual | $0 | $0 | $0 | $387000 |
| Surprise | -100.0% | -100.0% | -100.0% | -80.7% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 31, 2024 | $-0.16 | $-0.72 | 77.8 % |
| Q2 | Jul 31, 2024 | $-0.59 | $-0.77 | 23.4 % |
| Q1 | May 14, 2024 | $-0.10 | $-0.87 | 88.5 % |
| Q4 | Mar 27, 2024 | $-2.18 | $-1.14 | -91.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 31, 2024 | $0 | $450.00K | -100.0 % |
| Q2 | Jul 31, 2024 | $0 | $460.00K | -100.0 % |
| Q1 | May 14, 2024 | $0 | $720.00K | -100.0 % |
| Q4 | Mar 27, 2024 | $387.00K | $2.00M | -80.7 % |
